90888-04-3

Usage

Uses

Used in Pharmaceutical Industry:
(3-IODOPHENOXY) ACETIC ACID ETHYL ESTER is utilized as a pharmaceutical intermediate for the synthesis of various pharmaceutical drugs and active ingredients. Its chemical properties make it a valuable component in the development of new medications, contributing to the advancement of healthcare and pharmaceutical research.
Used in Research and Development:
In the realm of scientific research and development, (3-IODOPHENOXY) ACETIC ACID ETHYL ESTER serves as a starting material for the creation of new chemical compounds. Its unique structure and reactivity provide a foundation for exploring novel chemical reactions and syntheses, potentially leading to the discovery of innovative products and applications.
Used in Agricultural Applications:
(3-IODOPHENOXY) ACETIC ACID ETHYL ESTER has potential applications in agriculture, where it may be employed as a pesticide or herbicide. Its chemical properties could offer effective solutions for controlling pests and unwanted plant growth, thereby contributing to more efficient and productive agricultural practices.
It is crucial to handle (3-IODOPHENOXY) ACETIC ACID ETHYL ESTER with care, adhering to safety guidelines to mitigate any risks associated with its potentially hazardous nature. Proper handling and safety measures ensure the safe and effective use of (3-IODOPHENOXY) ACETIC ACID ETHYL ESTER in various applications.

InChI:InChI=1/C10H11IO3/c1-2-13-10(12)7-14-9-5-3-4-8(11)6-9/h3-6H,2,7H2,1H3

Upstream product

• 626-02-8 3-Iodophenol 
• 105-36-2 ethyl bromoacetate 
• 64-17-5 ethanol 
• 1878-93-9 (3-iodophenoxy)acetic acid 

Downstream Products

• 13359-14-3 <3-Iod-phenoxy>-acethydroxamsaeure 
• 1082059-05-9 ethyl 2-(3-(phenylethynyl)phenoxy)acetate 
• 1234312-38-9 ethyl 2-[3-(diisopropoxyphosphoryl)phenoxy]acetate 
• 1265140-90-6 C₂₅H₂₅NO₅ 
• 1265140-92-8 C₂₅H₂₅NO₅ 
• 1265140-93-9 C₂₅H₂₅NO₅ 
• 1265140-94-0 C₂₅H₂₅NO₄ 
• 1265140-95-1 C₂₅H₂₅NO₄ 
• 1265140-96-2 C₂₅H₂₅NO₄ 
• 1878-93-9 (3-iodophenoxy)acetic acid 

Relevant academic research and scientific papers

NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS

Novel substituted condensed pyrimidine compounds of general formula (I) in which the chemical groupings, substituents and indices are as defined in the description, and to their use as medicaments, in particular as medicaments for the treatment of conditions and diseases that can be treated by inhibition of the PDE4 enzyme.

Synthesis and properties of a novel type of acyclic nucleoside phosphonates: 2-(purin-9-yl)ethoxyphenylphosphonic acids

A series of novel acyclic nucleoside phosphonates with a built-in arylphosphonate moiety has been prepared by a microwave-assisted cross-coupling reaction as the key step. Their cytostatic and antiviral activities were tested. The pKa values of the target ortho-, meta- and para-substituted arylphosphonates were determined by 31P NMR titration studies.

High-yielding cleavage of (aryloxy)acetates

A reliable and high-yielding one-pot sequence for the removal of O-carboxymethyl moieties from phenols is presented. When diethylphosphoryl azide is employed as the azide transfer reagent in the Curtius rearrangement and glycerol in the subsequent hydrolytic workup, the protocol can be reliably applied to a very broad scope of substrates. Wiley-VCH Verlag GmbH & Co. KGaA, 2008.

Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA1/GPR40), a potential target for the treatment of type II diabetes

A series of 4-phenethynyldihydrocinnamic acid agonists of the free fatty acid receptor 1 (FFA1) has been discovered and explored. The preferred compound 20 (TUG-424, EC50 = 32 nM) significantly increased glucose-stimulated insulin secretion at 100 nM and may serve to explore the role of FFA1 in metabolic diseases such as diabetes or obesity.